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SYNOPSIS 
Thesis entitled “Synthetic Studies towards the Bioactive Natural Macrolides (Sorangicin A, 
Aspergillide B, Amphidinolactone A, Mycolactone Core) and Novel Biocompatible Organic 
Nano Materials” has been divided into four chapters. 
¾ Chapter I: This chapter describes development of new methodology and its 
application to the synthesis of bioactive complex natural products. This chapter is 
subdivided into three sections. 
• Section A: Iodine-catalyzed stereoselective synthesis of trans-2,6-disubstituted 
3,6-dihydro-2H-pyran ring systems. 
• Section B: Application to the concise construction of C28-C37 bicyclic core of 
(+)-Sorangicin A. 
• Section C: Application to concise formal total synthesis of proposed structure of 
Aspergillide B. 
¾ Chapter II: This chapter describes stereoselective total synthesis of Amphidinolactone 
A. 
¾ Chapter III: This chapter deals with the studies towards the stereoselective synthesis 
of Mycolactone ring system. 
¾ Chapter IV: This chapter describes synthesis and characterization of novel organic 
nano materials and their biocompatibility studies.   
 
Chapter I: 
Heterocyclic compounds are broadly distributed in Nature, and constitute an integral component 
of several polyketides, adding a significant degree of conformational rigidity in natural products 
and thus likely to be critical to the pharmacophore of biological activity. Among them, 2,6-
disubstituted dihydropyrans, are probably one of the most common structural motifs spread 
across various natural products, from simple glucose to structurally complex secondary 
metabolites such as lulinaolide; leucascandrolide A; aspergillide A, B, and C; misakinolides; 
phorboxazole; laulimalide; swinholides; scytophycins; and even more elaborated architectures 
present in polytoxins, maitotoxins, and other marine derived natural products. As a result, several 
approaches have been reported for the preparation of dihydropyrans. Many of these reactions 
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have limitations, such as the need for strictly anhydrous conditions, stoichiometric quantities of a 
Lewis acid initiator, or delivery of a strong Lewis acid at a low temperature. To avoid the above 
limitations, we have to search for a catalyst with high catalytic activity, easy availability, short 
reaction time, environment friendly and simple work-up procedure. Molecular iodine attracted 
our attention as recently it has attained considerable importance in organic synthesis because of 
low cost, nontoxic nature, ready availability, environment-friendly, easy handling, and high 
efficiency for various organic transformations to the corresponding products in excellent yields 
with high diastereoselctivity. Since it has been used as a mild Lewis acid catalyst for the 
activation of carbonyl compounds, including acetalization reactions, we envisaged that iodine 
could catalyze the reaction for the formation of 2,6-disubstituted-3,4-dihydropyrans starting from 
δ-hydroxy α,β-unsaturated aldehydes. 
 
Chapter I, Section A: 
We report our research on the use of iodine as a catalyst for the construction of trans-2,6-
disubstituted-3,4-dihydropyran under neutral reaction conditions starting from δ-hydroxy δ,β-
unsaturated aldehydes. In a model reaction, δ-hydroxy-enal 3 was treated with 
allyltrimethylsilane in CH3CN using 5 mol % of iodine as a catalyst.  After 12 h at room 
temperature, the reaction afforded the expected trans-2,6-disubstituted-3,4-dihydropyran 4 in 
42% yield 
.  
 
 
 
Scheme 1: Reagents and conditions: (a) vinyl magnesium bromide, CuI, −20 oC, 88%; (b) Hoveyda-
Grubbs catalyst, rt, 85%; (c) allyltrimethylsilane, I2, 45 min, 90%. 
 
The stereochemistry of the product was confirmed by through investigation of spectral data. To 
optimize the reaction conditions, screening was performed on several parameters, such as 
solvents, temperature, and catalyst concentration. THF was found to be superior to other 
solvents. The use of 10 mol% molecular iodine (based on δ-hydroxy α,β-unsaturated aldehyde) 
gave the best result with a yield of 91% after 30 min of reaction.  
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Table 1. Iodine-catalyzed synthesis of trans-2,6-disubstituted-3,4-dihydropyrans    
S. No. Product[a] Solvent Time (min)  Yield[b] 
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  To explain the formation of the trans-2,6-disubstituted-3,4-dihydropyran following catalytic 
pathways, we postulated that the product was generated with activation of aldehyde by in-situ 
formation of trimethylsilyl iodide and subsequent formation of an oxonium intermediate in 
which the stereoelectronic and/or steric factors dictate the direction of the incoming nucleophile 
(Scheme 2). To test the viability of the proposed reaction pathways, we conceived that the 
reaction of a δ-hydroxy α,β-unsaturated aldehyde in presence of catalytic amount of 
trimethylsilyl iodide (TMSI) should generate the corresponding trans-2,6-disubstituted- 3,4-
dihydropyran. Pleasingly, when 10 mol% of TMSI was added instead of molecular iodine at 
room temperature, the reaction completed in 10 min, which strongly supported our proposed 
mechanism                    
 
 
 
 
 
 
 
 
 
 
Scheme 2: Proposed mechanism 
 
.In conclusion, we have developed a novel, practical protocol for the construction of 2,6-
disubstituted-3,4-dihydropyrans starting from δ-hydroxy δ,β-unsaturated aldehydes. 
 
Chapter I, Section B: 
 
To demonstrate the applicability and generality of our method to complex biologically active 
natural products syntheses, we were interested in targeting the C28–C37 bicyclic ether core 16 of 
marine macrolactone (+)-sorangicin A (15).  
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Retrosynthesis: 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3 
 
We initiated the synthesis (Scheme 3) of 16 with a known secondary alcohol 17, which was 
obtained through asymmetric crotylation of commercially available benzyloxyacetaldehyde in 
96% ee under conditions originally developed by Brown and Bhat. In order to obtain the 
unsaturated aldehyde 18, a cross-metathesis (CM) between 17 and acrolein (6.0 equiv) was 
achieved using Hoveyda-Grubbs catalyst 16a (10 mol%) in CH2Cl2 at room temperature for 24 h 
afforded the required δ-hydroxy α,β-unsaturated aldehyde 18 in 84% yield. On treatment of 18 
with 10 mol% molecular iodine in THF at room temperature gave the trans-2,6-disubstituted-
3,4-dihydropyran 13 in 90% yield. One step conversion of terminal olefin to aldehyde 19 was 
achieved by modified dihydroxylation followed by oxidative cleavage of the diol in 80% yield 
over two steps. Direct catalytic asymmetric α-aminoxylation of the resulting aldehyde by using 
enantiopure proline as the catalyst and nitrosobenzene as the oxygen source and in situ reduction 
gave the 1,2-diol 20 in 61% yield over three steps. Selective protection of the primary hydroxyl 
group as its TBDPS ether yielded 20 in 92% yield. The newly created stereogenic center was 
confirmed by modified Mosher’s method. Treatment of 21 with NIS in CH3CN furnished the 
corresponding iodo ether derivative 22 as a single isomer in 81% of yield. De-iodination was 
achieved smoothly by treatment of 22 with Bu3SnH and AIBN in toluene under reflux conditions 
to obtain 16 in 94% yield. The product was confirmed by 1H, 13C NMR and HRMS data. The 
stereochemistry of the advanced intermediate was ascertained by NOE experiments.  
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Scheme 4: Reagents and Conditions: (a) Acrolein, Hoveyda-Grubbs catalyst, rt, 84%; (b) 
allyltrimethylsilane, I2, 45 min, 90%; (c) NaIO4, 2,6 Lutidine, OsO4, dioxane: H2O(3:1), 1h, 92%; (d) 
PhNO, D-Proline, NaBH4, CuSO4.5H2O, MeOH, 12h, 61%; (e) TBDPSCl, imid, rt, 1h, 92%; (f) NIS, 
CH3CN, rt, 24h, 81%; (g) AIBN, Bu3SnH, reflux, 30min, 95%. 
 
In conclusion, we have demonstrated the broad scope of the protocol to the construction of C28-
C37 fragment of (+)-sorangicin A in 8 steps with 21% overall yield. 
 
Chapter I, Section C: 
Three 14-membered macrolides, named aspergillides A, B and C, were isolated from 
marine-derived fungus Aspergillus ostianus strain 01F313, cultured in a medium composed of 
bromine-modified artificial seawater by T. Kusumi et al. in 2007. The structures of the new 
compounds were determined by analyses of 1D and 2D NMR spectra. Their structures were 
proposed to be heptaketidic 14-membered macrolides and absolute configurations were 
elucidated by the modified Mosher’s method and chemical conversions. These three Macrolides 
were found to show cytotoxic activities in the micromolar range against mouse lymphocytic 
leukaemia cells (L1210).  
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We were attracted to Aspergillide B because of their unique structural motif and 
interesting biological activity. The major challenge from the synthetic point of view is the 
construction of the bridged tetrahydropyran ring with required trans stereochemistry.  
We envisioned that this goal could be achieved by our recently developed methodology 
and the trans olefin as well as the macrolactone could be achieved by a late stage RCM protocol.  
 
Retrosynthesis:  
 
 
 
 
 
 
 
 
 
 
Scheme 5 
 
Our synthesis started (Scheme 6) from racemic PMB protected glycidol (28) which was resolved 
with (S, S) Jacobsen’s Co(III) salen to obtain 29 in 44% of yield and 98% ee. This chiral epoxide 
when treated with THP protected propargyl alcohol in presence of BuLi and BF3.OEt2, furnished 
30 in 92% yield. The THP group was deprotected with p-TsOH in MeOH to produce diol 31 
which was consequently reduced to E-olefin 32 with Red-Al in THF in 83% yield over two 
steps. The primary hydroxy of the diol 32 was selectively oxidized with BAIB, TEMPO to 
furnish 33. With δ-hydroxy α,β-unsaturated  aldehyde 33 in hand, our next target was to make 
the trans-fused pyran ring 34 which was achieved by our own developed methodology using 
allyltrimethylsilane as a reagent and I2 as a catalyst in 91% yield. One step conversion (Scheme 
7) of terminal olefin 34 to aldehyde was achieved by modified dihydroxylation followed by 
oxidative cleavage of the diol in 80% yield over two steps. The aldehyde was oxidized to acid 35 
by Pinnick oxidation which was converted to 38 by two different routes. First, we carried out 
iodo lactonization using I2, KI in saturated NaHCO3 which produced the iodo lactone 36 
 
 
 
 
O
HO
OO O
TBSO
O OH
OH
ASPERGILLIDE B (23)
RCM
Iodo
Esterification
Jacobsen's HKR
24
27
or
Pd catalyzed
Wacker type
oxidation
H
H
O
PMBO
O
OH
25
PMBO
OH
H
O
26
                                                                                 23 
 
 
 
 
 
 
 
 
Scheme 6: Reagents and conditions: (a) (S,S) Jacobsen’s Co(III) salen, 12 h, rt,  44%, >98%ee; (b) n-BuLi, 
BF3.(OEt)2, −78 oC, 1 h. 92%; (c) p-TsOH, MeOH, 1 h, 95%; (d) Red-Al, rt, 12 h, 87%; (e) BAIB, 
TEMPO, rt, 3 h, 85%; (f) allyltrimethylsilane, I2 (10 mol%), rt, 30 min, 91%. 
 
 
 
 
 
 
 
 
 
 
 
Scheme 7: Reagents and conditions: (g) NaIO4, OsO4, 2,6 lutidine, 3 h, 80% ; (h) NaClO2, NaH2PO4, 2-
methyl-2-butene; (i) I2, KI, NaHCO3, 6 h, 70%; (j) TBTH, AIBN, Benzene, reflux, 85%; (k) Pd(OAc)2, 
Cu(OAc)2.2H2O, O2, DMSO, 10 h, 95%; (l) Pd/C, H2, 1 h, quantitative.  
 
in moderate yield. De-iodination was carried out using Bu3SnH, AIBN in refluxing benzene to 
give the desired lactone 38 in 85% of yield. But, when we performed Pd-catalyzed Wacker type 
oxidation and hydrogenation protocol, we achieved 38 with 95% yield over two steps. This 
lactone was cleaved to its hydroxy acid (Scheme 8) by LiOH and then selectively protected to its 
TBS ether by TBSOTf, imidazole, DMAP in dry DMF to furnish 39 with 81% yield. The acid 39 
was coupled with 27 under Yamaguchi condition and then PMB group was deprotected using 
DDQ to produce the alcohol 41 which was oxidized with Dess-Martin Periodinane and subjected 
to Wittig olefination to furnish the diene 43. The diene when treated with Grubbs 2nd generation 
catalyst, 44 was formed as the sole product with 78% yield. Finally, TBS group was deprotected 
with TBAF to furnish the target molecule aspergillide B 23. 
In conclusion, we have developed a concise, stereoselective route for Aspergillide B. 
Moreover, we have demonstrated the versatility of our developed methodology for natural 
product synthesis. 
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Scheme 8: Reagents and conditions: (m) LiOH, TBSOTf, imidazole, DMAP, 6 h, 81%; (n) 2,4,6 
trichlorobenzoyl chloride, 27, 3 h, 85%; (o) DDQ, CH2Cl2:H2O/ 9:1, rt, 90%; (p) Dess-Martin 
Periodinane, rt; (q) PPh3CH2Br, n-BuLi; (r) G-II, CH2Cl2, Reflux, 3 h, 78%;  (s) TBAF, THF, 0 oC, 1h, 
90%. 
 
 
Chapter II: Protecting Group Directed Intramolecular Nozaki-Hiyama-Kishi Reaction: 
A Concise and Convergent Stereoselective Total Synthesis of Amphidinolactone A 
Amphidinolactone A (45) is a cytotoxic 13-membered macrolide, which was isolated 
from a symbiotic dinoflagellate Amphidinium sp. (Y-25) separated from an Okinawan marine 
acoel flatworm Amphiscolops sp. Their relative stereochemistry was determined by extensive 
NMR studies. Recently, Masahiro et al. reported first total synthesis amphidinolactone A and 
thus they confirmed that the absolute stereochemistry was identical with the proposed one (8R, 
11S and 12R). But their approach was associated with some limitation, e.g. long reaction 
sequence, non stereoselective and less overall yield. 
Retrosynthesis: 
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Due to its intriguing biological activity and structural complexity and to circumvent all 
the problems associated with the earlier synthesis, we initiated its total synthesis in a convergent 
manner. To achieve the asymmetric total synthesis we planned to perform stereoselective 
intramolecular NHK coupling reaction, Wittig olefination and Lindlar’s reduction as depicted 
above. 
Our synthesis (Scheme 10) started from racemic PMB protected Glycidol (28) which was 
resolved with (S, S) Jacobsen’s Co(III) salen giving 29 in 44% of yield and 98%ee. This chiral 
epoxide when treated with 51 in presence of BuLi and BF3.OEt2, furnished 52 in 92% of yield. 
OBn protection, TBS deprotection with p-TsOH/MeOH and hydrogenation with 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 10: Reagents and Conditions: (b) n-BuLi, BF3.(OEt)2, 90%; (c) NaH, BnBr, 90%; (d) p-TsOH, 
MeOH, 91%; (e) H2, Pd/C on CaCO3, quinoline, 95%; (f) i)IBX, DMSO; ii) NaClO2, NaH2PO4, 2-methyl 
2-butene, 85% over two steps; (g) CH2N2, 96%; (h) DDQ, CH2Cl2:H2O/ 9:1, 89%; (i) i)DMP, 92%; ii) 
CrCl2, CHI3, 82%; (j) LiOH, THF:H2O/ 3:1, 91%. 
 
Lindlar catalyst furnished 55, which was subsequently oxidized to acid 56 by a two step 
sequence. This acid was converted to its methyl ester 57 using diazomethane and then PMB 
group was deprotected by DDQ to give the alcohol 58. It was converted to aldehyde by DMP 
which was further used for Takai olefination to give E-vinyl iodide 59 with good yield. Ester 59 
was saponified to acid 48 using LiOH in THF/H2O. 
To reach the second fragment, we again started (Scheme 11) from 29 which was treated 
with TBS protected homo propargyl alcohol in presence of BuLi and BF3.OEt2 to furnished 60 in 
90% of yield. TBDPS group was deprotected with p-TsOH/MeOH and diol 61 was selectively 
mono tosylated with TsCl and then subsequently converted to Iodo 63 using NaI 
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Scheme 11: Reagents and Conditions: a) n-BuLi, BF3.(OEt)2, 90%;  b) p-TsOH, MeOH; c) TsCl, Et3N; d) 
NaI, acetone, reflux. e) TPP, CH3CN, 100 oC; g) n-BuLi, Propionaldehyde; f) H2, Pd/C on CaCO3, 
quinoline. 
 
on refluxing acetone. It was converted to its TPP salt 64 for Wittig olefination. When this salt 
was treated with BuLi and propanal, it produced Z-olefin 65 as a sole product. Finally, 
hydrogenation with Lindlar’s catalyst furnished the desired compound 50. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 12: Reagents and conditions: (a) i) DCC, DMAP, CH2Cl2, 0 oC-rt, 12 h, 58%; ii) EDCI, DMAP, 
CH2Cl2, 0 oC-rt, 12 h, 70%; iii) 2,4,6-trichlorobenzoyl chloride, DMAP, THF, toluene, rt, 6 h, 89%; (b)  
DDQ, CH2Cl2:H2O /9:1, rt, 3 h, 91%; (c) DMP, CH2Cl2, rt, 4 h; (d) CrCl2, NiCl2, DMSO, rt, 24 h, 81% 
over two steps. 
 
With these two fragments in hand, our next task was to couple this two fragments which 
was achieved by 2,4,6 trichlorobenzoyl chloride under standard Yamaguchi esterification 
condition to produce 46 (Scheme 12). PMB group was deprotected with DDQ to give 66 which 
were then oxidized to their corresponding aldehydes using DMP as oxidizing agents. When, the 
most crucial NHK coupling was carried out in DMSO and THF (3:1) mixture, high yield was 
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obtained although the reaction took about 24 h to completely consume the starting material. A 
smooth reaction ensured to afford a 2:1 mixture of inseparable diastereomeric allylic alcohols 
68a/ 68b in 84% yield. 
To obtain a single isomer at this juncture forced us for the judicious choice of the 
protecting group which can determine and influence the carbonyl facial selection. To make 
TBDPS protected vinyl iodide 49, we started from 52, which was treated with TBDPSCl, 
imidazole in dry DMF to give 69. Then we carried out the same reaction sequences to reach 49 
as depicted below (Scheme 13). To our surprise, TBDPS protected compound produced the 
desired product exclusively. Finally, TBDPS group was deprotected by TBAF to produce the 
final natural product 45 whose analytical data were in good agreement with the natural one. 
  
 
 
 
 
 
 
 
 
 
Scheme 13: Reagents and Conditions: (a)TBDPSCl, Imidazole, DMF, 97%; (b) p-TsOH, MeOH, 89%; 
(c) H2, Pd/C on CaCO3, quinoline, 96%; (d) i) TEMPO, BAIB, CH2Cl2, rt, 3 h, 91%;  ii) NaClO2, 
NaH2PO4, 2-methyl 2-butene, 94%; (e) CH2N2, 95%; (f) DDQ, CH2Cl2:H2O/ 9:1, 88%; (g) i) DMP, 96%; 
ii) CrCl2, CHI3, 84%; (h) LiOH, THF:H2O/ 3:1, 90%. 
 
In conclusion, we have accomplished the total synthesis of amphidinolactone A (1) in 13 
longest linear steps and 22.6% overall yield from 9. The important feature of our synthetic route 
is an  
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Scheme 14: Reagents and conditions: (a) 2,4,6-trichlorobenzoyl chloride, DMAP, THF, toluene, rt, 6 h, 
87%; (b)  DDQ, CH2Cl2:H2O (9:1), rt, 3 h, 92%; (c) DMP, CH2Cl2, rt, 4 h; (d) CrCl2, NiCl2, DMSO, rt, 24 
h, 85% over two steps; (e) TBAF, AcOH, THF, 0 oC-rt, 1 h, 87%. 
 
intramolecular Nozaki-Hiyama-Kishi reaction for macrocyclization to construct 13-membered 
lactone and control of stereochemical outcome, after esterification between two key 
intermediates prepared by concise and efficient synthetic protocol.     
 
Chapter III: Synthetic studies towards the synthesis of Mycolactone Core. 
Mycobacterium ulcerans is the causative agent of Buruli ulcer, a severe human skin disease that 
occurs primarily in Africa and Australia. Infection with M. ulcerans results in persistent severe 
necrosis without an acute inflammatory response. Despite several attempts, no compound 
responsible for the cytopathic effect of this organism has been identified till 1999, when Small et 
al2 identified the toxin and found it to be a polyketide. To reflect its mycobacterial source and 
chemical structure the toxin isolated from Mycobacterium Ulcerans has been named as 
Mycolactones A and B. Mycolactones are the first toxin isolated from Mycobacteria species as 
well as the first complex polyketide produced by a human pathogen.  
Our synthesis started from commercially available propylene oxide (Scheme 16) which was 
resolved by (S, S) Jacobsen’s Co(III) salen with >98% ee and 38% yield. This chiral epoxide was 
opened with 84 using BuLi, BF3.OEt2 at −78 o C. After PMB protection and THP deprotection, 
the alkyne was reduced to Z-olefin 88 using H2, Ni(acac)2, NaBH4 protocol. This Z allyl alcohol 
 Retrosynthesis: 
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was subjected to Sharpless asymmetric epoxidation using (+) DIPT, Ti(iOPr)4, TBHP to get the 
epoxy alcohol 89 which was oxidized to aldehyde with IBX followed by Horner- Wittig-Emons 
olefination to produce 90 in good yield. A complete stereoselective epoxide opening was 
achieved by (CH3)3Al in CH2Cl2/H2O to produce the secondary alcohol 91 which was protected 
as its TBS ether 92 by TBSOTf, Lutidine. 
 
 
 
 
 
 
 
 
 
 
 
Scheme 16: Reagents and conditions: (a) (S,S) Jacobsen’s Co(III) Salen; (b) n-BuLi, BF3.(OEt)2, 90%; (c) 
PMBBr, NaH, rt, 95%; (d) p-TsOH, MeOH, rt, 91%; (e) Ni(acac)2, NaBH4, EtOH, H2, rt, 98% ; (f) (+) 
DIPT, Ti(iOPr)4, TBHP, −20 oC, 72%; (g) i) IBX, DMSO, rt; ii) (OEt)2P(O)CH2CO2Et, NaH, rt, 83%; (h) 
(CH3)3Al, CH2Cl2-H2O, −40 oC, 88%. 
 
The α, β unsaturated ester 92 was reduced to ally alcohol 93 by DIBAL-H and then 
converted to epoxy alcohol 94 under standard Sharpless asymmetric epoxidation condition using 
(−) DET, Ti(iOPr)4, TBHP as reagents. The alcohol 94 was converted to iodo 95 which was 
directly treated with Zn dust/ NaI in refluxing methanol to afford allyl alcohol 83 (Scheme 17) 
and then, after column purification, was converted to its propionate ester 96. Treatment 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 17: Reagents and conditions: (a) TBSOTf, 2,6 Lutidine, 0 oC, 1 h, 95%; (b) DIBAL-H, 0 oC, 2 h, 
91% ; (c) (−) DET, Ti(iOPr)4, TBHP, −20 oC, 3 h, 89%; (d) I2, TPP, Imidazole; (e) Zn dust, NaI, MeOH, 6 
h, 82%; (f) (CH3CH2O)2O, Et3N; (g) LDA, TMSCl, −78 oC, 3 h, 78% over two steps; (h) CH3NH(OCH3), 
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EDCI, HOBt, rt, 12 h, 85%; (i) i) DIBAL-H, 1 h , −78 oC ; ii) TMSSCH2CH2STMS, ZnI2, 12 h, 70% over 
two steps. 
 
 with LDA, TMSCl at −78 oC,  underwent a facile Ireland-Claisen rearrangement to produce the 
acid 97 as a single diastereomeric product. It was converted to Weinreb amide 97 followed by 
treatment with DIBAL-H at −78 oC to afford aldehyde which was subsequently protected as 
thioketal 79 using TMSSCH2CH2STMS as reagent and ZnI2 as a catalyst. 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 18: Reagents and conditions: (a) SeO2, Salicylic acid, TBHP, 24 h, 60%; (b) i) MsCl, TEA, 0 oC, 
1 h; ii) NaI, acetone, 30 mins, 80% over 2 steps; (c) LiHMDS, −78 oC, 3 h, 75%; (d) LiBH4, THF:MeOH / 
4:1, 1 h, 94%; (e) i) TEMPO, BAIB, 1 h; ii) CH(PPh3)CO2Et, 1 h, 88% over 2 steps; (f) DIBAL-H, 1 h, 
96%; (g) (−)DET, Ti(iOPr)4, TBHP, -20 oC, 8 h, 82%; (h) IBX, DMSO, 3 h, (i) (EtO)2 P(O)CH2CO2Et, 
NaH, RT, 1 h, 80%. 
 
Our synthesis for the second fragment started from (Scheme 18) Benzyl protected prenyl 
alcohol 99 which was oxidized with SeO2, TBHP to produce allyl alcohol 100 and then 
converted to iodo 101 by two step sequences. The iodo 101 when coupled with the auxiliary 102 
under standard Evans alkylation condition furnished 103 with 72% yield with >98% de. The 
auxiliary was cleaved with LiBH4 followed by oxidation and treatment with C-2 ylide to produce 
α,β unsaturated ester 105. DIBAL-H reduction produced allyl alcohol 82 which was subjected to 
Sharpless asymmetric epoxidation with (−) DET, Ti(iOPr)4, TBHP to give 106. This was 
converted to 81 (Scheme 19) by following two step sequence, oxidation and then HWE 
olefination. Next, our most crucial step was regioselective reductive epoxide opening to produce 
108 which was achieved by using Pd2(dba)3.CHCl3, TPP as a catalyst and HCOOH acid as 
hydrogen source. This newly formed secondary hydroxy group was protected with TBSOTf to 
get 109 followed by selective reduction with NiCl2, NaBH4 to afford its saturated ester 110. The ester 
functionality was reduced to alcohol and protected as TBDPS ether to give 112. Benzyl 
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deprotection was achieved by Li, naphthalene which was subsequently converted to its iodo 
derivative 80. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Scheme 19: Reagents and conditions: (a) Pd2(dba)3.CHCl3 (5 mol%), PPh3( 5 mol%), HCO2H, Et3N, 3 h, 
70%; (b) TBSOTf, 2,6 Lutidine, 0 oC, 30 min, 95%; (c) NiCl2, NaBH4, EtOH, 2 h, 90%; (d) DIBAL-H, 1 
h, 96%; (e) TBDPSCl, Imidazole, 1 h, 97%; (f) Li, Naphthalene, 4h, −20 oC, 84%; (g) i) MsCl, TEA, 0 
oC, 1h; ii) LiBr, Acetone, 30 min, 86% over steps. 
 
With fragments 79 and 80 in hand, our next target was to perform Umpolung coupling  between 
these two. When we tried with n-BuLi, t-BuLi and t-BuOK-n-BuLi, an intractable mixture of 
product was obtained. 
 
In conclusion, we have developed a stereoselective, concise route for the synthesis of the 
C1-C10 and C1-C19 fragment. 
 
Chapter IV: Synthesis of novel organic nano materials and their biocompatibility studies. 
 
The discoveries of buckminsterfullerene (C60) and single-walled carbon nanotubes 
(SWNTs) represent two very significant advances in the last two decades. Both types of material 
have found utility in important areas such as superconductivity and molecular electronics. Whilst 
the synthesis and fictionalization of carbon nanotubes is now developing rapidly, the materials 
produced are often costly, irregular in shape, and are typically found to aggregate in large 
bundles, thus making manipulation somewhat less than straightforward. Given the intense focus 
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on buckyballs and SWNTs, it is surprising that significantly less efforts have been directed to 
developing the synthesis of alternative multicomponent organic nanospheres and tubules. 
Recently, organic tubular assemblies are of interest due to their numerous possible applications, 
many of which are evident from a consideration of biological systems. Inspired by the 
remarkable functions of tubular structures in biology, much research has focussed on the 
construction of simpler synthetic tubes via self-assembly. Major focus of nanomaterial 
development leads to bioimaging and potential use as vehicles for therapeutic delivery. 
Biomaterial delivery relies on three important factors: chemical modification, biocompatibility 
and minimal damage of the transported tissues/organs. We therefore developed nanomaterials 
exhibiting fluorescence either intrinsic or resulting from fluorescent molecules embedded during 
self-assembly that may be used as bioimaging agents both in vivo and in vitro by inhibiting rapid 
bleaching effect.  
PABA (p-aminobenozic acid) is a natural non-protein amino acid which is frequently 
found  as a structural moiety in drugs with a wide range of therapeutic applications, such as: 
antibacterial, local anesthetic, anti-arrhythmic, gastrokinetic etc. So, we envishioned PABA  
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could be the right choice as an integral component of nano materials for biocompatibility. 
Our previous studies already showed that amino pyridine moiety plays an important role for 
self aggregation. Herein, we report the preparation of PABA and amino pyridine based nano 
materials, their characterization and cell viability studies.  
Our chemical synthesis started from p-nitro benzoic acid which was converted to its 
acid chloride by (COCl)2 and then subsequently coupled with 2-amino pyridine to produce 
nitro benzamide. The nitro functionality was reduced to amine under hydrogenatmosphere 
using Pd/C as a catalyst. This amine was subsequently coupled with various acid chlorides to 
furnish final benzamides which were converted to different nano material of different shape 
and size. 
Preparation and isolation of nano materials: To obtain self-assembled nanomaterials, each 
compound (1 mg) were added in methanol (2 mL) and heated to 60oC till it dissolved 
completely. Deionized water (2 mL) was added slowly at the same temperature to obtain a milky 
white solution which upon slow cooling to room temperature furnished cotton-like 
 
 
 
                        
 
 
 
 
 
 
 
 
 
 
Scheme 22 
white aggregates. To prepare rhodamine B embedded fluorescent nanotube, rhodamine B 
solution (0.1 mL, 1 mg of rhodamine B in 5.0 mL of deionized water) was added to a preheated 
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methanolic solution (1 mg in 2ml) prior to the addition of deionized water (2 mL) which on 
cooling produced pink-colored fluorescent aggregates. These aggregates were isolated under 
centrifuged conditions (4,500 rpm for 20 min) followed by overnight drying at 60 oC to afford 
0.5 mg of final nano tubes of different shape and size. 
Mechanism for self aggregation: The mechanism and the driving forces for the formation of 
nanometric morphologies are not clearly understood. As the two compounds posses a 
pyridine, benzene and alkyl chain, it is likely that hydrogen bonding, Π-Π interactions and 
van der Waals interactions play a major role in directing the aggregation and subsequent 
nanotube formation. The FT-IR study revealed two absorption bands of antisymmetric (νas) 
symmetric (νs) CH2 stretching vibrational modes at 2920 cm-1 and 2850 cm-1 respectively 
which confirmed the presence of a highly ordered trans structure in the aliphatic region8. The 
absence of Amide A band attributed to free NH group (over 3430 cm-1) and presence of N-H 
stretching frequency near 3310 cm-1 further indicates that all NH- groups are involved in an 
extensive hydrogen- bonding network. The CO stretching band at around 1600 and 1659 cm-
1 (amide I), and the NH bending peak near 1517cm-1 (amide II) suggest β-sheets for the 
molecules in the solid state which are known to form weakly curved sheets. The presence of  
sheets, half-tubes and nanotubes give evidence for the “rolling mechanism”. The formation 
of the tubular structures may occur by a closure of the extended sheet along one axis of the 
two-dimensional layer. 
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Cell viability test: 
 
 
 
 
 
 
 
Figure 2: Cellular uptake of the PNT-A 
nanotube  in human HEK-293 cells. 
 
 
 
 
 
 
Figure 1: (A) and (B) Fluorescence Images of 
nanotubes PNT-A (from 119) and PNT-B (from 
112); (Scale bar of A is 5µm and B is 10µm); 
(C) SEM image of nanotubes from 112; (D) 
TEM image of nanotubes from 112; (E) and (F) 
SEM images of nanotubes from 119; The scale 
bars in the panels C,D,E and F are 8µm,                               
Figure 3: Uptake of two different (PNT-A, 
PNT-B) nanotubes in mouse embryonic stem 
cells 1µm, 4µm and 20µm respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
